PATH (UiPath, NYSE) closes at $10.10 on 26 Feb 2026: AI pivot tests valuation
PATH stock closed at $10.10 on 26 Feb 2026 after a 1.61% intraday rise. The session finished with 32,097,400 shares traded versus an average volume of 31,519,439. UiPath Inc. (PATH) trades on the NYSE in USD and now sits well below its 50-day average of $14.84. Investors will watch the March 11, 2026 earnings date and how management positions agentic AI in the enterprise automation stack.
PATH stock: close, volume and session snapshot
UiPath (PATH) ended the market session at $10.10 on 26 Feb 2026. Volume reached 32,097,400 shares, above the average volume of 31,519,439. The intraday range ran from $9.92 to $10.43, and the one-year low remains $9.38.
Earnings calendar and recent PATH news
UiPath reports next on 2026-03-11 with analysts watching EPS and margin guidance closely. Last quarter the company posted $0.16 EPS and $411.11M revenue, beating estimates. Recent institutional moves include Vanguard raising its stake, noted by MarketBeat source. Sector commentary comparing PATH to peers appeared on Nasdaq source.
Valuation and key financial metrics for PATH stock
UiPath trades at a trailing P/E of 25.50 with EPS of $0.42. Price-to-sales is 3.69 and price-to-book is 3.00. The company shows a current ratio of 2.54 and cash per share of $2.59, supporting liquidity and investment in AI R&D.
Meyka AI grade and forecast for PATH stock
Meyka AI rates PATH with a score out of 100 as 76.18, Grade B+, Suggestion: BUY. This grade factors S&P 500 and sector comparison, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a yearly price of $15.48, implying a 53.27% upside from $10.10. Forecasts are model-based projections and not guarantees.
Technicals and trading signals for PATH stock
Technicals show RSI at 25.72, flagged oversold, and MACD slightly negative. The 50-day average is $14.84, and the 200-day average is $13.54. Bollinger bands place the middle at $11.82, with lower band at $9.57, highlighting short-term support.
Sector context, risks and opportunities for PATH stock
UiPath sits in Technology, Software – Infrastructure, benefiting from AI automation demand. Partnerships with Microsoft and OpenAI are strategic opportunities. Risks include competition from cloud providers and margin pressure from increased investment. Institutional ownership is high at about 62.50%, while insiders recent selling equals 23.19% ownership sold.
Final Thoughts
UiPath (PATH) closed at $10.10 on 26 Feb 2026 with elevated volume and an oversold technical profile. The company shows solid liquidity, a trailing P/E of 25.50, and revenue growth near 23.57% year over year. Meyka AI’s model projects a yearly target of $15.48, implying roughly 53.27% upside from today. Near-term catalysts include the March 11, 2026 earnings release and product rollouts around agentic AI agents. Key risks are competition from Microsoft Power Automate and cloud vendors, and the need to balance R&D spending with margin expansion. We view PATH stock as a growth-oriented AI exposure with a B+ Meyka grade, but forecasts are model-based projections and not guarantees. Use these data points in portfolio context and align risk tolerance to the stock’s volatility and sector dynamics. Meyka AI is an AI-powered market analysis platform and these insights form part of our broader research.
FAQs
What drove PATH stock today?
PATH stock rose to $10.10 on 26 Feb 2026 driven by elevated volume, recent institutional buying, and positioning ahead of the March 11 earnings report.
What is the Meyka AI forecast for PATH stock?
Meyka AI’s forecast model projects a yearly price of $15.48, implying about 53.27% upside from $10.10. Forecasts are model-based projections and not guarantees.
Is PATH stock undervalued compared to peers?
PATH trades at a trailing P/E of 25.50 and price-to-sales of 3.69, cheaper than some AI infrastructure peers but facing stronger competition. Valuation depends on growth execution.
What are the main risks for PATH stock?
Key risks for PATH stock include large tech competition, execution on AI agent strategy, and margin pressure from increased R&D and go-to-market spend.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.